A detailed history of Israel Englander (Millennium Management LLC) transactions in Erasca, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,410,550 shares of ERAS stock, worth $6.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,410,550
Previous 814,773 195.86%
Holding current value
$6.27 Million
Previous $1.92 Million 242.35%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.17 - $3.28 $3.46 Million - $5.23 Million
1,595,777 Added 195.86%
2,410,550 $6.58 Million
Q2 2024

Aug 14, 2024

SELL
$1.79 - $2.63 $607,449 - $892,508
-339,357 Reduced 29.4%
814,773 $1.92 Million
Q1 2024

May 15, 2024

SELL
$1.67 - $2.55 $551,898 - $842,718
-330,478 Reduced 22.26%
1,154,130 $2.38 Million
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.49 $491,100 - $732,239
294,072 Added 24.7%
1,484,608 $3.16 Million
Q2 2023

Aug 14, 2023

SELL
$2.57 - $3.3 $1.09 Million - $1.4 Million
-423,976 Reduced 26.26%
1,190,536 $3.29 Million
Q1 2023

May 15, 2023

BUY
$2.74 - $4.44 $3.53 Million - $5.72 Million
1,287,474 Added 393.68%
1,614,512 $4.86 Million
Q4 2022

Feb 14, 2023

SELL
$3.89 - $8.57 $130,062 - $286,537
-33,435 Reduced 9.28%
327,038 $1.41 Million
Q3 2022

Nov 14, 2022

BUY
$5.82 - $10.68 $2.1 Million - $3.85 Million
360,473 New
360,473 $2.81 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $318M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.